Navigation Links
RMi Introduces SyntheSight™ Pharma Multi-Channel Optimization Suite
Date:1/4/2012

DES MOINES, Iowa, Jan. 4, 2012 /PRNewswire/ -- Pharmaceutical marketers who need to calibrate multi-channel marketing and sales resources and spending to maximize ROI have limitless questions. SyntheSight™, a new proprietary pharmaceutical multi-channel marketing optimization methodology developed by RMi with a patent-pending IntelliScore™, provides actionable insights and ad hoc reporting to help brand leaders find answers.

SyntheSight features two primary components: OptiView™, an online dashboard environment, provides an action-oriented view of program performance and recommendations to optimize results; and IntelliScore features a real-time customer interaction quotient reflecting engagement and facilitating investment optimization for ROI.

"The pharmaceutical industry is struggling with accountability of multi-channel marketing spending and reliably predicting and measuring ROI," said Andrea Westmeyer, RMi president. "SyntheSight methodology allows our clients to carefully calibrate their brand marketing and sales functions based on real measurable marketing insights, and to better leverage that knowledge for increased brand sales, or throughout their enterprise or franchise."

RMi client Jay Appel, director of physician relationship marketing at Amgen, has had SyntheSight in test use for over one year. "This is the future of our business," he said. "From first impression to engagement to behavioral change, the SyntheSight methodology enables us to effectively evaluate key tactics as we optimize our multi-channel marketing."

According to Westmeyer, SyntheSight users engaged in multi-channel marketing programs have 51 percent greater physician engagement than programs utilizing sales alone. By month six of a SyntheSight –managed, multi-channel marketing program, 62 percent of targets were engaged with one or more program elements. On average, multi-channel marketing programs utilizing SyntheSight have produced an 11.8 percent sales lift for RMi clients, she noted.

Westmeyer said SyntheSight methodology offers marketers a real-time view of their customers to drive sales for a single brand, or to better leverage data insights to benefit multiple brands in an enterprise. According to Westmeyer, RMi's clients are using SyntheSight to fill the "actionable insights knowledge gaps" in their marketing organizations to help answer questions, such as:

  • Was marketing spend optimized? (Right target, message, choice of tactics? Positive ROI?)
  • What was the sales lift from marketing spend? Which tactics worked best?
  • Can I predict or forecast lost sales?
  • Can we leverage category insights into successful physician engagement from one brand to another?

"Breaking barriers to physician engagement requires cutting through the clutter with marketing and sales programs carefully calibrated to optimize sales growth, while controlling costs," Westmeyer concluded. "SyntheSight methodology in practice produces real. measurable. insight.™ which offers scalable solutions for any brand, franchise or enterprise marketing to HCPs."

About RMi

RMi is a peerless team of HCP marketing engagement specialists who break barriers, clutter and records with best-of-breed measurement and optimization strategies and technology to engage targets and increase sales. SyntheSight™, RMi's proprietary pharmaceutical industry multichannel optimization methodology, provides nearly real-time actionable insights to optimize sales and marketing spend. To learn more visit http://sales.rmarketing.com for a short video and capabilities overview.

CONTACT:

John Dutcher, APR, Dutcher & Associates, L.L.C.

515/334-3464; dna@qwestoffice.net

Or

Andrea Westmeyer, RMi

917/749-6875; awestmeyer@Rmarketing.com

 

™ SyntheSight, OptiView and IntelliScore are registered trademarks of RMi.

™ real. measurable. insight. is a registered trademark of RMi.


'/>"/>
SOURCE RMi
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Quest Diagnostics Introduces ClariSure(TM) Test for Identifying Chromosome Abnormalities Associated With 85 Developmental Disorders in Children
2. Dr. Dello Russo Introduces the New EYE-Q Lasik
3. Caliper Life Sciences Introduces Drug Combination Services to Identify Synergistic Response of Compounds
4. Wedgewood Introduces Refresh(TM) Exchange-Program: Free Exchange of Expired Veterinary Compounded Medications Solves Key Industry Problem
5. CeloNova BioSciences Introduces a New Class of Coronary Stent: The CATANIA(TM) Coronary Stent System with NanoThin Polyzene(R)-F
6. Thermo Fisher Scientific Introduces Breakthrough in RNA-Interference Technology
7. Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C
8. Siemens Introduces New Standard of Care for Breast Ultrasound
9. Perceptive Informatics Introduces Medical Imaging Methodology to Accelerate Development Decisions About Alzheimers Treatments
10. Quest Diagnostics Introduces First Commercial Laboratory Test for Identifying the H1N1 Swine Flu Virus
11. VivoMetrics(R) Introduces Next Generation LifeShirt Prototype, a Smart Garment That Delivers Real-time Vital Signs Remotely to Healthcare Providers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... , Ungarn, February 12, 2016 ... das sich auf den ungedeckten medizinischen Bedarf ... positive Ergebnisse seines klinischen Forschungsprogramms bekannt. Das ... beschäftigt, ergab Verbesserungen ihrer respiratorischen Funktionen und ... ltd , ein Medizintechnikunternehmen, das sich auf ...
(Date:2/11/2016)... , Feb. 11, 2016 ... Diagnostics in Personalized Medicine and Cancer Therapy. - ... High-Growth Diagnostic Testing Markets. - Key Diagnostic Testing ... - Molecular Diagnostics in Genetic Testing. - Molecular ... Markets. - Over-the-Counter Diagnostic Products World Markets. ...
(Date:2/11/2016)... Stem cells are primitive cells found in ... the capacity to differentiate into mature cell types Stem ... first mouse embryonic stem cells were derived from embryos ... the first culturing of embryonic stem cells from non-human ... until 2006 As a result of these discoveries, stem ...
Breaking Medicine Technology:
(Date:2/13/2016)... Canada (PRWEB) , ... February 13, 2016 , ... In ... foot forward. They’ll groom themselves to perfection, go out of their way to be ... date – just take a look at any online dating profile. , A ...
(Date:2/12/2016)... DC (PRWEB) , ... February ... ... Siemens Foundation today announced a new initiative—the Siemens Foundation-PATH Ingenuity Fellowships—to develop ... The partnership will recruit top students from U.S. universities who will draw ...
(Date:2/12/2016)... ... , ... As a former television executive, owner Tal Rabinowitz knows how stressful ... decompress, Rabinowitz found herself drawn to a casual meditation class while working at NBC ... implementing a 20-minute-per-day meditation practice with her team. After her tenure at NBC, she ...
(Date:2/12/2016)... , ... February 12, 2016 , ... Every winter, someone ... This winter the West Penn Burn Center, part of the Allegheny Health ... to bring you the “Space Heaters Need Space” campaign. , “Space ...
(Date:2/12/2016)... ... , ... Erlanger Agency has announced a new partnership in its ongoing community ... on the fight against breast cancer, fundraising for a local woman named Carmen, who ... Carmen is a loving single mother of two boys who also serves as caregiver ...
Breaking Medicine News(10 mins):